Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 157

1.

Vaccination in Multiple Sclerosis: Friend or Foe?

Zrzavy T, Kollaritsch H, Rommer PS, Boxberger N, Loebermann M, Wimmer I, Winkelmann A, Zettl UK.

Front Immunol. 2019 Aug 7;10:1883. doi: 10.3389/fimmu.2019.01883. eCollection 2019. Review.

PMID:
31440255
2.

Persistence of the immune response after vaccination with the Japanese encephalitis vaccine, IXIARO® in healthy adults: A five year follow-up study.

Taucher C, Kollaritsch H, Dubischar KL.

Vaccine. 2019 May 1;37(19):2529-2531. doi: 10.1016/j.vaccine.2019.03.030. Epub 2019 Apr 5.

3.

Age-related differences in humoral and cellular immune responses after primary immunisation: indications for stratified vaccination schedules.

Wagner A, Garner-Spitzer E, Jasinska J, Kollaritsch H, Stiasny K, Kundi M, Wiedermann U.

Sci Rep. 2018 Jun 29;8(1):9825. doi: 10.1038/s41598-018-28111-8.

4.

Immunogenicity and safety of the inactivated Japanese encephalitis vaccine IXIARO® in elderly subjects: Open-label, uncontrolled, multi-center, phase 4 study.

Cramer JP, Dubischar K, Eder S, Burchard GD, Jelinek T, Jilma B, Kollaritsch H, Reisinger E, Westritschnig K.

Vaccine. 2016 Aug 31;34(38):4579-4585. doi: 10.1016/j.vaccine.2016.07.029. Epub 2016 Jul 25.

PMID:
27460550
5.

[Guidelines for vaccination of immunocompromised individuals].

Wiedermann U, Sitte HH, Burgmann H, Eser A, Falb P, Holzmann H, Kitchen M, Köller M, Kollaritsch H, Kundi M, Lassmann H, Mutz I, Pickl WF, Riedl E, Sibilia M, Thalhammer F, Tucek B, Zenz W, Zwiauer K.

Wien Klin Wochenschr. 2016 Aug;128 Suppl 4:337-76. doi: 10.1007/s00508-016-1033-6. Epub 2016 Jul 25. German.

PMID:
27457874
6.

Genetic Variation of Bordetella pertussis in Austria.

Wagner B, Melzer H, Freymüller G, Stumvoll S, Rendi-Wagner P, Paulke-Korinek M, Repa A, Mooi FR, Kollaritsch H, Mittermayer H, Kessler HH, Stanek G, Steinborn R, Duchêne M, Wiedermann U.

PLoS One. 2015 Jul 16;10(7):e0132623. doi: 10.1371/journal.pone.0132623. eCollection 2015.

7.

Persistence of antibodies six years after booster vaccination with inactivated vaccine against Japanese encephalitis.

Paulke-Korinek M, Kollaritsch H, Kundi M, Zwazl I, Seidl-Friedrich C, Jelinek T.

Vaccine. 2015 Jul 9;33(30):3600-4. doi: 10.1016/j.vaccine.2015.05.037. Epub 2015 May 30.

PMID:
26036947
8.

Rotavirus vaccines: a story of success.

Kollaritsch H, Kundi M, Giaquinto C, Paulke-Korinek M.

Clin Microbiol Infect. 2015 Aug;21(8):735-43. doi: 10.1016/j.cmi.2015.01.027. Epub 2015 Feb 11. Review.

9.

A Novel multivalent OspA vaccine against Lyme borreliosis is safe and immunogenic in an adult population previously infected with Borrelia burgdorferi sensu lato.

Wressnigg N, Barrett PN, Pöllabauer EM, O'Rourke M, Portsmouth D, Schwendinger MG, Crowe BA, Livey I, Dvorak T, Schmitt B, Zeitlinger M, Kollaritsch H, Esen M, Kremsner PG, Jelinek T, Aschoff R, Weisser R, Naudts IF, Aichinger G.

Clin Vaccine Immunol. 2014 Nov;21(11):1490-9. doi: 10.1128/CVI.00406-14. Epub 2014 Sep 3.

10.

Safety and immunogenicity of modified vaccinia Ankara as a smallpox vaccine in people with atopic dermatitis.

von Sonnenburg F, Perona P, Darsow U, Ring J, von Krempelhuber A, Vollmar J, Roesch S, Baedeker N, Kollaritsch H, Chaplin P.

Vaccine. 2014 Sep 29;32(43):5696-702. doi: 10.1016/j.vaccine.2014.08.022. Epub 2014 Aug 20.

PMID:
25149431
11.

The burden of pneumococcal meningitis in Austrian children between 2001 and 2008.

Klobassa DS, Zoehrer B, Paulke-Korinek M, Gruber-Sedlmayr U, Pfurtscheller K, Strenger V, Sonnleitner A, Kerbl R, Ausserer B, Arocker W, Kaulfersch W, Hausberger B, Covi B, Eitelberger F, Vécsei A, Simma B, Birnbacher R, Kurz H, Zwiauer K, Weghuber D, Heuberger S, Quehenberger F, Kollaritsch H, Zenz W.

Eur J Pediatr. 2014 Jul;173(7):871-8. doi: 10.1007/s00431-013-2260-8. Epub 2014 Jan 14.

PMID:
24419336
12.

Gender-specific distribution of mefloquine in the blood following the administration of therapeutic doses.

Wernsdorfer WH, Noedl H, Rendi-Wagner P, Kollaritsch H, Wiedermann G, Mikolasek A, Karbwang J, Na-Bangchang K.

Malar J. 2013 Dec 9;12:443. doi: 10.1186/1475-2875-12-443.

13.

[Vaccination recommendations for health care workers in Austria].

Wiedermann U, Rendi-Wagner P, Aigner G, Bechter E, Druml C, Falb P, Holzmann H, Karbus G, Kollaritsch H, Kundi M, Presterl E, Szymanski EE, Tucek B, Zenz W, Zwiauer K.

Wien Klin Wochenschr. 2014 Apr;126 Suppl 1:S11-22. doi: 10.1007/s00508-013-0461-9. Epub 2013 Nov 19. Review. German.

PMID:
24249329
14.

Characteristics of invasive pneumococcal disease in hospitalized children in Austria.

Paulke-Korinek M, Kollaritsch H, Kundi M, Schmidle-Loss B, Zwazl I, Laaber B, Lakovits K, Vecsei A, Wiedermann U, Burgmann H.

Eur J Pediatr. 2014 Apr;173(4):469-76. doi: 10.1007/s00431-013-2193-2. Epub 2013 Nov 13.

PMID:
24221605
15.

Tick-borne encephalitis (TBE) and hepatitis B nonresponders feature different immunologic mechanisms in response to TBE and influenza vaccination with involvement of regulatory T and B cells and IL-10.

Garner-Spitzer E, Wagner A, Paulke-Korinek M, Kollaritsch H, Heinz FX, Redlberger-Fritz M, Stiasny K, Fischer GF, Kundi M, Wiedermann U.

J Immunol. 2013 Sep 1;191(5):2426-36. doi: 10.4049/jimmunol.1300293. Epub 2013 Jul 19.

16.

Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial.

Wressnigg N, Pöllabauer EM, Aichinger G, Portsmouth D, Löw-Baselli A, Fritsch S, Livey I, Crowe BA, Schwendinger M, Brühl P, Pilz A, Dvorak T, Singer J, Firth C, Luft B, Schmitt B, Zeitlinger M, Müller M, Kollaritsch H, Paulke-Korinek M, Esen M, Kremsner PG, Ehrlich HJ, Barrett PN.

Lancet Infect Dis. 2013 Aug;13(8):680-9. doi: 10.1016/S1473-3099(13)70110-5. Epub 2013 May 10.

PMID:
23665341
17.

Sustained low hospitalization rates after four years of rotavirus mass vaccination in Austria.

Paulke-Korinek M, Kollaritsch H, Aberle SW, Zwazl I, Schmidle-Loss B, Vécsei A, Kundi M.

Vaccine. 2013 May 31;31(24):2686-91. doi: 10.1016/j.vaccine.2013.04.001. Epub 2013 Apr 15.

PMID:
23597718
18.

Factors associated with seroimmunity against tick borne encephalitis virus 10 years after booster vaccination.

Paulke-Korinek M, Kundi M, Laaber B, Brodtraeger N, Seidl-Friedrich C, Wiedermann U, Kollaritsch H.

Vaccine. 2013 Feb 18;31(9):1293-7. doi: 10.1016/j.vaccine.2012.12.075. Epub 2013 Jan 7.

PMID:
23306371
19.

Vaccines and vaccination against tick-borne encephalitis.

Kollaritsch H, Paulke-Korinek M, Holzmann H, Hombach J, Bjorvatn B, Barrett A.

Expert Rev Vaccines. 2012 Sep;11(9):1103-19. doi: 10.1586/erv.12.86. Review.

PMID:
23151167
20.

Traveler's Diarrhea.

Kollaritsch H, Paulke-Korinek M, Wiedermann U.

Infect Dis Clin North Am. 2012 Sep;26(3):691-706. doi: 10.1016/j.idc.2012.06.002. Review.

PMID:
22963778
21.

Cell culture (Vero cell) derived whole-virus non-adjuvanted H5N1 influenza vaccine induces long-lasting cross-reactive memory immune response: homologous or heterologous booster response following two dose or single dose priming.

van der Velden MV, Aichinger G, Pöllabauer EM, Löw-Baselli A, Fritsch S, Benamara K, Kistner O, Müller M, Zeitlinger M, Kollaritsch H, Vesikari T, Ehrlich HJ, Barrett PN.

Vaccine. 2012 Sep 21;30(43):6127-35. doi: 10.1016/j.vaccine.2012.07.077. Epub 2012 Aug 8.

PMID:
22884662
22.

Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.

Ehrlich HJ, Müller M, Kollaritsch H, Pinl F, Schmitt B, Zeitlinger M, Loew-Baselli A, Kreil TR, Kistner O, Portsmouth D, Fritsch S, Maritsch F, Aichinger G, Pavlova BG, Barrett PN.

Vaccine. 2012 Jun 22;30(30):4543-51. doi: 10.1016/j.vaccine.2012.03.061. Epub 2012 Apr 1.

PMID:
22475864
23.

Persistence of antibodies in 4-8 year old Austrian children after vaccination with hexavalent DTaP-HBV-IPV/Hib and MMR vaccines.

Paulke-Korinek M, Fischmeister G, Grac A, Rendi-Wagner P, Kundi M, Mohsenzadeh-Rabbani A, Moritz K, Fenninger B, Jarisch R, Jasinska J, Holzmann H, Wiedermann U, Kollaritsch H.

Vaccine. 2011 Jul 18;29(32):5130-6. doi: 10.1016/j.vaccine.2011.05.046. Epub 2011 May 30.

PMID:
21624412
24.

The current perspective on tick-borne encephalitis awareness and prevention in six Central and Eastern European countries: report from a meeting of experts convened to discuss TBE in their region.

Kollaritsch H, Chmelík V, Dontsenko I, Grzeszczuk A, Kondrusik M, Usonis V, Lakos A.

Vaccine. 2011 Jun 20;29(28):4556-64. doi: 10.1016/j.vaccine.2011.04.061. Epub 2011 May 5. Review.

PMID:
21549781
25.

Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria.

Paulke-Korinek M, Kundi M, Rendi-Wagner P, de Martin A, Eder G, Schmidle-Loss B, Vecsei A, Kollaritsch H.

Vaccine. 2011 Mar 24;29(15):2791-6. doi: 10.1016/j.vaccine.2011.01.104. Epub 2011 Feb 12.

PMID:
21320539
26.

Long term immunity following a booster dose of the inactivated Japanese Encephalitis vaccine IXIARO®, IC51.

Eder S, Dubischar-Kastner K, Firbas C, Jelinek T, Jilma B, Kaltenboeck A, Knappik M, Kollaritsch H, Kundi M, Paulke-Korinek M, Schuller E, Klade CS.

Vaccine. 2011 Mar 21;29(14):2607-12. doi: 10.1016/j.vaccine.2011.01.058. Epub 2011 Feb 1.

PMID:
21288804
27.

A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE.

von Krempelhuber A, Vollmar J, Pokorny R, Rapp P, Wulff N, Petzold B, Handley A, Mateo L, Siersbol H, Kollaritsch H, Chaplin P.

Vaccine. 2010 Feb 3;28(5):1209-16. doi: 10.1016/j.vaccine.2009.11.030. Epub 2009 Nov 25.

28.

Universal mass vaccination against rotavirus gastroenteritis: impact on hospitalization rates in austrian children.

Paulke-Korinek M, Rendi-Wagner P, Kundi M, Kronik R, Kollaritsch H.

Pediatr Infect Dis J. 2010 Apr;29(4):319-23. doi: 10.1097/INF.0b013e3181c18434.

PMID:
19935446
29.

Booster vaccinations against tick-borne encephalitis: 6 years follow-up indicates long-term protection.

Paulke-Korinek M, Rendi-Wagner P, Kundi M, Laaber B, Wiedermann U, Kollaritsch H.

Vaccine. 2009 Nov 23;27(50):7027-30. doi: 10.1016/j.vaccine.2009.09.068. Epub 2009 Sep 26.

PMID:
19786143
30.

IC51 Japanese encephalitis vaccine.

Kollaritsch H, Paulke-Korinek M, Dubischar-Kastner K.

Expert Opin Biol Ther. 2009 Jul;9(7):921-31. doi: 10.1517/14712590903042282. Review.

PMID:
19527110
31.

Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study.

Kaltenböck A, Dubischar-Kastner K, Eder G, Jilg W, Klade C, Kollaritsch H, Paulke-Korinek M, von Sonnenburg F, Spruth M, Tauber E, Wiedermann U, Schuller E.

Vaccine. 2009 Jul 16;27(33):4483-9. doi: 10.1016/j.vaccine.2009.05.034. Epub 2009 May 30.

PMID:
19486955
32.

National paediatric immunization program of high risk groups: no effect on the incidence of invasive pneumococcal diseases.

Rendi-Wagner P, Paulke-Korinek M, Kundi M, Burgmann H, Georgopoulos A, Vécsei A, Kollaritsch H.

Vaccine. 2009 Jun 19;27(30):3963-8. doi: 10.1016/j.vaccine.2009.04.044. Epub 2009 May 3.

PMID:
19393711
33.

Pretravel consultation: rapid dipstick test as a decision guidance for the application of tetanus booster vaccinations.

Paulke-Korinek M, Rendi-Wagner P, Kundi M, Tomann B, Wiedermann U, Kollaritsch H.

J Travel Med. 2008 Nov-Dec;15(6):437-41. doi: 10.1111/j.1708-8305.2008.00252.x.

34.

Correlation between humoral and cellular immune responses and the expression of the hepatitis A receptor HAVcr-1 on T cells after hepatitis A re-vaccination in high and low-responder vaccinees.

Garner-Spitzer E, Kundi M, Rendi-Wagner P, Winkler B, Wiedermann G, Holzmann H, Herzog C, Kollaritsch H, Wiedermann U.

Vaccine. 2009 Jan 7;27(2):197-204. doi: 10.1016/j.vaccine.2008.10.045. Epub 2008 Nov 7.

PMID:
18996424
35.

Prophylactic immunisation against traveller's diarrhoea caused by enterotoxin-forming strains of Escherichia coli and against cholera: does it make sense and for whom?

Weinke T, Liebold I, Burchard GD, Frühwein N, Grobusch MP, Hatz C, Kollaritsch H, Nothdurft HD, Reisinger E, Rieke B, Schönfeld Ch, Steffen R, Stich A.

Travel Med Infect Dis. 2008 Nov;6(6):362-7. doi: 10.1016/j.tmaid.2006.05.003.

PMID:
18984481
36.

Effect of pre-existing anti-tick-borne encephalitis virus immunity on neutralising antibody response to the Vero cell-derived, inactivated Japanese encephalitis virus vaccine candidate IC51.

Schuller E, Klade CS, Heinz FX, Kollaritsch H, Rendi-Wagner P, Jilma B, Tauber E.

Vaccine. 2008 Nov 11;26(48):6151-6. doi: 10.1016/j.vaccine.2008.08.056. Epub 2008 Sep 17.

PMID:
18804132
37.

Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51 Six and 12 month results of a multicenter follow-up phase 3 study.

Schuller E, Jilma B, Voicu V, Golor G, Kollaritsch H, Kaltenböck A, Klade C, Tauber E.

Vaccine. 2008 Aug 12;26(34):4382-6. doi: 10.1016/j.vaccine.2008.05.081. Epub 2008 Jun 17.

PMID:
18599165
38.

Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccine.

Tauber E, Kollaritsch H, von Sonnenburg F, Lademann M, Jilma B, Firbas C, Jelinek T, Beckett C, Knobloch J, McBride WJ, Schuller E, Kaltenböck A, Sun W, Lyons A.

J Infect Dis. 2008 Aug 15;198(4):493-9. doi: 10.1086/590116. Erratum in: J Infect Dis. 2010 Apr 15;201(8):1278.

PMID:
18588481
39.

Vaccination with Dukoral against travelers' diarrhea (ETEC) and cholera.

Jelinek T, Kollaritsch H.

Expert Rev Vaccines. 2008 Jul;7(5):561-7. doi: 10.1586/14760584.7.5.561. Review.

PMID:
18564011
40.

[Rabies, a neglected threat].

Paulke-Korinek M, Kollaritsch H.

Med Monatsschr Pharm. 2008 Feb;31(2):53-8; quiz 59-60. Review. German.

PMID:
18368978
41.

After a tick bite in a tick-borne encephalitis virus endemic area: current positions about post-exposure treatment.

Bröker M, Kollaritsch H.

Vaccine. 2008 Feb 13;26(7):863-8. doi: 10.1016/j.vaccine.2007.11.046. Epub 2007 Dec 4. Review.

PMID:
18206274
42.

Pharmacodynamic interaction between monodesbutyl-benflumetol and artemisinin as well as proguanil in Plasmodium falciparum in vitro.

Raffelsberger J, Wernsdorfer G, Sirichaisinthop J, Kollaritsch H, Congpuong K, Wernsdorfer WH.

Wien Klin Wochenschr. 2008;120(19-20 Suppl 4):90-4. doi: 10.1007/s00508-008-1038-x.

PMID:
19066781
43.

Interaction between lumefantrine and monodesbutyl-benflumetol in Plasmodium falciparum in vitro.

Starzengruber P, Kollaritsch H, Sirichaisinthop J, Wernsdorfer G, Congpuong K, Wernsdorfer WH.

Wien Klin Wochenschr. 2008;120(19-20 Suppl 4):85-9. doi: 10.1007/s00508-008-1080-8.

PMID:
19066780
44.

Japanese encephalitis and vaccines: past and future prospects.

Paulke-Korinek M, Kollaritsch H.

Wien Klin Wochenschr. 2008;120(19-20 Suppl 4):15-9. doi: 10.1007/s00508-008-1071-9. Review.

PMID:
19066766
45.

Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial.

Tauber E, Kollaritsch H, Korinek M, Rendi-Wagner P, Jilma B, Firbas C, Schranz S, Jong E, Klingler A, Dewasthaly S, Klade CS.

Lancet. 2007 Dec 1;370(9602):1847-53.

PMID:
18061060
46.

[Medical clearance for missions abroad (EEU): definitions, recommendations for use and performance].

Kollaritsch H, Wenisch C, Hatz C, von Laer G, Bauer B, Hollenstein U, Haditsch M, Diridl G, Malinowski W, Jeschko E, Payer-Neundlinger G, Speiser-Remp N, Pichler HE, Rumpold H, Stemberger H, Eder G, Wiedermann G, Wiedermann U.

Wien Klin Wochenschr. 2007;119(19-20 Suppl 3):13-25. Review. German. Erratum in: Wien Klin Wochenschr. 2009 Oct;121 Suppl 3:following 56.

PMID:
17987354
47.

Impact of a pertussis booster vaccination program in adolescents and adults on the epidemiology of pertussis in Austria.

Rendi-Wagner P, Paulke-Korinek M, Stanek G, Khanakah G, Kollaritsch H.

Pediatr Infect Dis J. 2007 Sep;26(9):806-10.

PMID:
17721375
48.

Epidemiology of travel-associated and autochthonous hepatitis A in Austrian children, 1998 to 2005.

Rendi-Wagner P, Korinek M, Mikolasek A, Vécsei A, Kollaritsch H.

J Travel Med. 2007 Jul-Aug;14(4):248-53.

49.

Antibody persistence following booster vaccination against tick-borne encephalitis: 3-year post-booster follow-up.

Rendi-Wagner P, Paulke-Korinek M, Kundi M, Wiedermann U, Laaber B, Kollaritsch H.

Vaccine. 2007 Jun 28;25(27):5097-101. Epub 2007 Feb 20.

PMID:
17555850
50.

The risk of acquiring hepatitis A and B among travelers in selected Eastern and Southern Europe and non-European Mediterranean countries: review and consensus statement on hepatitis A and B vaccination.

Nothdurft HD, Dahlgren AL, Gallagher EA, Kollaritsch H, Overbosch D, Rummukainen ML, Rendi-Wagner P, Steffen R, Van Damme P; ad hoc Travel Medicine Expert Panel for ESENEM.

J Travel Med. 2007 May-Jun;14(3):181-7. No abstract available.

Supplemental Content

Loading ...
Support Center